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Von Willebrand factor (vWF) is a complex multimeric protein whose main function in hemostasis is to facilitate the binding of platelets to exposed subendothelium at sites of vascular injury. In humans and in several species of domestic animals, vWF has been shown to be comprised of polymers of a basic subunit with a molecular mass of approximately 230-250 kD. 1, 4, 7, 8 These subunits are linked by disulfide bonds into a family of multimers that, when assessed in plasma by sodium dodecyl sulfate (SDS) electrophoresis, range in size from about 1 to 20 MD in approximately 1-MD increments. The higher molecular mass multimers seem to have the greatest functional activity. 1, 15 Quantitative and/or qualitative deficiencies of vWF account for the group of congenital bleeding disorders collectively known as von Willebrand's disease (vWD) . vWD is a particularly common cause of excessive bleeding in humans and dogs. 7, 9, 12 Acquired expressions of vWF deficiency have also been reported. 9, 12 The analysis of the multimeric structure of vWF (multimeric analysis = MA) in plasma and platelets currently forms the basis for the differentiation of the major types and subtypes of human vWD.
Molecular sieving electrophoresis of vWF multimers in agarose or polyacrylamide-agarose gels in the presence of SDS and urea has been widely applied in various MA techniques. The technical complexity of MA and the use of radiolabeling to identify the vWF multimers initially limited this diagnostic procedure to larger research facilities. 13 Newer modifications to MA, in which vWF multimers are electroeluted and/or visualized by enzyme-linked labeling of vWF multimers, have now made the application of MA more adaptable to other types of laboratory situations, including veterinary diagnostic laboratories. 2, 10, 11 Low-resolution gel techniques (terminology based primarily on separating gel characteristic) allow for the separation of the highest molecular weight vWF multimers, and high resolution gels generally improve the resolution of individual lower molecular weight bands, permitting discrimination of subbands within each multimer. 5, 7, 13, 15 In humans, type I vWD is characterized by a quantitative deficiency of plasma vWF but a full range of multimer sizes is detectable with low-resolution MA. Type II vWD is characterized by a normal or reduced amount of plasma vWF protein, but there is a significant reduction or absence of the higher molecular weight multimers. Type III vWD, or severe vWD, is characterized by extremely low levels of plasma von Willebrand factor antigen (vWF:Ag), and therefore there are essentially no identifiable multimers. A similar typing classification has been adapted to canine vWD. 6, 7, 9 From The Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.
Received for publication March 4, 1996. The ability to identify these major vWD types has both prognostic and therapeutic significance. 6, 9, 12 Subtypes of the type I and II forms of human vWD are characterized by specific subband abnormalities in plasma and/or platelet vWF, which are identifiable with high-resolution gel techniques. 2, 14, 15 For the diagnosis of human vWD, a low-resolution gel could be used to screen plasmas, and where a type II form is identified, a high-resolution gel could be used to subclassify the variant form. 3 The purpose of this paper is to describe a low-resolution technique for the analysis of vWF multimers in canine plasma using SDS electrophoresis, semidry electrotransfer onto nitrocellulose, and enzyme labeling as a means for visualizing the vWF multimers. The technique has been used to assess the spectrum of multimer sizes in canine plasma and to screen for variant forms of canine vWD. This technique has also be used to assess vWF multimer profiles in plasmas from several other domestic animal species.
Plasma samples were obtained from fresh blood samples drawn by clean venipuncture into 3.8% trisodium citrate at a ratio of 1 part anticoagulant to 9 parts blood. Dogs with vWD were identified through a screening program for canine hemostatic disorders using accepted diagnostic criteria, which included clinical history, pedigree analysis, and quantitative and qualitative assessments of vWF. 7,9 Plasma vWF:Ag was quantitated by enzyme-linked immunosorbent assay, and the quality of the vWF was assessed using a newly developed vWF-collagen binding assay (unpublished observations). The pooled plasma samples used in this study were each prepared using 6-10 clinically normal adult individuals of the appropriate species. Plasma samples were stored at -70 C until assayed.
This MA technique utilized a 1.5% separating gel prepared using high-gelling-temperature (HGT) agarose a dissolved at 100 C in separating gel buffer (0.5 M Tris-base, b 0.1% SDS b pH 8.8) and cooled to 60 C before use. A 1-mm-thick gel was prepared by pouring this agarose between 2 preheated 205 x 125-mm glass plates separated by a U-frame spacer and held together by large clamps. The gel was then allowed to polymerize at room temperature for 2-3 hours in a sealed plastic bag. After polymerization, the upper glass plate was carefully removed and a 30-x 205-mm strip of separating gel was cut away. The plates were reassembled, and a volume of 0.8% HGT agarose in stacking gel buffer (0.125 M Trisbase, 0.1% SDS, pH 6.8) was added to replace the strip of separating gel. This agarose was also dissolved at 100 C and then cooled to 60 C before use. The finished gel was allowed to polymerize for 30-60 minutes at room temperature in a sealed plastic bag.
After polymerization, the upper plate and spacer were carefully removed, and the bottom plate holding the gel was placed on a template outlining the stacking gel/separating gel interface and the potential position of the eight 2-x 10-mm The empty wells were filled with stacking gel, and electrophoresis continued at a constant current of 11 mA until the tracking dye reached the stacking gel-separating gel interface (usually about 20 minutes). Electrophoresis was then continued overnight (approximately 18 hours) at a constant current of 5 mA with cooling to 14 C. The dye front would normally migrate 6-7 cm into the separating gel by the end of the electrophoresis period.
After electrophoresis, the gel was removed and placed in transfer buffer (0.025 M Tris-base, 0.192 M glycine, 0.1% SDS, 20% methanol, c pH 8.3) for 30 minutes with 1 change of buffer. The sandwich used for protein transfer consisted of (in order) a double layer of filter paper, e a sheet of nitrocellulose, f the agarose gel, and a second double layer of filter paper. All components were cut to the size of the gel and presoaked in transfer buffer. Air bubbles were eliminated during assembly of the sandwich by carefully rolling the various layers with a clean glass rod. The sandwich was aligned on the platinum anode of the semidry transfer unit, d and the cathode was placed on the stack and locked into position. Electrotransfer was performed at room temperature at 23 V for 30 minutes.
After transfer, the nitrocellulose was retrieved and washed for 60 min at room temperature (with gentle agitation) in Tris, bovine serum albumin (BSA) buffer (0.01 Tris HCl, b 0.9% NaCl, c 0.05% Tween 20 d containing 0.3% BSA, b pH 7.4). Following this wash, the buffer was replaced with a fresh volume of Tris/BSA buffer containing a 1:800 dilution of the rabbit anti-human vWF primary antibody. g After a 2-hour incubation at room temperature with gentle agitation, the nitrocellulose was washed 3 times (5 minutes per wash) in Tris buffer (0.01 M Tris HCl, 0.9% NaCl, 0.05% Tween 20, pH 7.4). The nitrocellulose was then incubated (1 hour at room temperature with gentle agitation) in a horseradish peroxidase-conjugated goat anti-rabbit second antibody h diluted 1:3,000 in the Tris/BSA buffer, followed by 3 washes (5 minutes each) with Tris buffer.
The visualization of the vWF multimers was made possible by incubating the nitrocellulose in substrate solution in the dark without agitation. This substrate buffer was prepared immediately before use and consisted of 20 ml of 0.01% 3,3diaminobenzidine HCl i in 0.1 M Tris HCl, 20 ml of distilled the staining intensity was deemed adequate, the reaction was stopped by washing the nitrocellulose 3 times in distilled water. The nitrocellulose was air dried and then photographed to produce a permanent record.
Typical vWF multimer profiles produced using canine plasma are shown in Figure 1 . With pooled normal canine plasma, 15-18 distinct and separate bands (multimers) could be consistently resolved on the original immunoblot. Some resolution was lost however with photographic reproduction. Bands were counted beginning with the smallest multimer, which, because it migrated most rapidly in the separating gel, was most distant from the origin. This resolution of at least 15 multimers is comparable with the resolution of other techniques using enzyme-linked labeling and is better than many procedures using autoradiography to visualize the multimers. 4, 6, 7, 11, 15 The higher molecular weight multimers positioned closer to the origin (cathode) were detectable with the immunostaining procedure but were less well resolved into discrete bands.
A Doberman pinscher with vWD that exhibited a mild clinical bleeding tendency had a plasma vWF:Ag concentration of only 16.1% (normal range = 60-170% of the canine pool) and demonstrated subnormal vWF : collagen binding activity. The MA for this dog's plasma (Fig. 1, lane 2) showed a normal spectrum of bands; however, the bands stained less intensely than did those in the pooled normal plasma assayed at the same time (Fig. 1, lane 1) . This laboratory profile of reduced concentration of plasma vWF (and therefore fainter bands) but a normal spectrum of vWF multimer sizes is consistant with a type 1 vWD classification. 7,9 The number and intensity of the vWF multimers visualized in the plasma from an individual normal dog with a plasma vWF:Ag concentration of 90.5% (Fig. 1, lane 3) was similar to that seen with the pooled normal canine plasma sample run concurrently. A German shepherd dog suffering from a previously undiagnosed, severe hemorrhagic diathesis characterized by a prolonged bleeding time, a normal blood platelet count, and normal coagulation screening test results had a low normal plasma vWF:Ag concentration (64.2%) but subnormal vWF: collagen binding activity. When MA was conducted on this dog's plasma (Fig. 1, lane 4) 9 small to intermediate bands could be identified on the original immunoblot, but there was a noticable absence of the higher molecular weight multimers. The MA pattern in this dog is consistant with a type II vWD classification. 7, 9, 15 The absence of large multimers, which are considered the more functionally active form of vWF, could explain the increased bleeding tendency in this dog. 1, 15 A Shetland sheepdog diagnosed with vWD (Fig.  1, lane 5) suffered from a severe clinical disorder and had a plasma vWF:Ag concentration of only 1.7% of normal and markedly subnormal vWF: collagen binding activity. On MA, only 1 faintly staining small-molecular-weight band could be identified. This profile could be consistant with a type III expression of vWD; however, in this case there was not an absolute deficiency of plasma vWF. MA of plasma from an Irish wolfhound considered on the basis of vWF:Ag quan-titation, vWF collagen binding, and pedigree analysis to be a probable carrier of vWD (Fig. 1, lane 6) revealed a normal range of vWF multimers, although the bands were fainter than those in the normal pooled plasma assessed at the same time (Fig. 1, lane 7) . This decreased staining intensity likely reflects the overall reduction in plasma vWF concentration (vWF:Ag = 50% of normal) despite the fact that all multimer sizes were represented. This Irish wolfhound was asymptomatic and underwent elective blood testing only because of his close relationship to another dog previously diagnosed with vWF deficiency. Pooled normal dog, horse, cow, goat, and pig plasmas were also studied using this MA technique. vWF multimers were resolved in each case (Fig. 2) , indicating good cross-reactivity between the vWF protein and antiserum raised in rabbits against human vWF; The band patterns produced by these pooled plasmas were remarkable similar; within all species, at least 15 bands were clearly identifiable. This result may reflect inter-species similarities in plasma vWF multimer size distribution and/or electrophoretic mobility. Similarities in the MA profiles and range of multimer sizes of vWF in normal human and normal canine plasma have been previously reported. 7 The porcine pooled plasma showed a greater resolution of high-molecular-weight bands, suggesting that there may be a greater degree of polymerization of the protein in the plasma of this species.
Although densitometer scanning was not performed in the present study, differences in the intensity of staining of the bands suggested quantitative differences in the amount of vWF protein present in the pooled plasmas from the various species. This suggestion was supported by quantitation of vWF:Ag concentrations in the different pooled plasmas. vWF:Ag concentrations in the feline, equine, bovine, caprine, and porcine pooled plasma samples were 153.5%, 78.9%, 56.3%, 108.8%, and 132.2%, respectively, when compared with the canine pool. However, these intraspecies differences may also reflect differing affinities of the vWF protein for the antibodies used.
The results indicate that this MA procedure can be adapted for use in species other than the dog and could be a useful diagnostic tool for evaluating plasma vWF in individuals of various species. Recently, this technique has been used to identify a type II MA profile in a horse with a clinical bleeding problem and other laboratory test results consistant with vWD (unpublished observations).
The advantages of the present technique for the assessment of vWF multimers are that it can be completed in a relatively short time (< 48 hours), it requires very small amounts of commercially available antibodies and other reagents, and it avoids the hazards of working with radioisotopes. The procedure provides good resolution of vWF multimers, including the HMW bands, and is therefore potentally useful in differentiating between type I and type II expressions of canine vWD. This technique can also be used to examine vWF multimer patterns in feline, equine, bovine, caprine, and porcine plasma and therefore is potentially valuable for assessing vWF in these species.
